Upcoming research needs to advance the existing discoveries and initiate the teasing out of some of the unknown issues highlighted such as—can TNF-α inhibitor therapy recover certain subgroups of populations with depression who present with higher inflammatory biomarkers, and may existing levels of TNF-α or other inflammatory biomarkers in individuals with depression indicate who is likely to respond to therapy? This evidence concerns the gene TNF and depressive disorder.